Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Panuveitis

• Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study
• POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU
• A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis
• A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-Uveitis
• Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis
• Ozurdex Monotherapy Trial
• A Trial of the Efficacy and Safety Trial of ABY-035 in the Treatment and Prevention of Relapse/Recurrence of Non-anterior Uveitis
• Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)
• Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis
• Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis
• Ocular Sarcoidosis Open Label Trial of ACTHAR Gel
• Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis
• Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
• Study of FTY720 in Patients With Uveitis
• Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
• Pilot Study of a Fluocinolone Acetonide Intravitreal Insert (FA-i) to Treat Intermediate-, Posterior-, or Panuveitis
• Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study
• Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
• Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,
• Intravitreal Sirolimus as Therapeutic Approach to Uveitis
• A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
• Sirolimus as Therapeutic Approach to Uveitis
• Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis
• Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis
• Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
• A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis
• A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis
• A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis
• Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)